pathogenesis, we analyzed polymorphisms of six mitochondrial genes,
Abstract:
Spinocerebellar ataxia type 3(SCA3) is a degenerative neurological disorders caused by trinucleotide repeat expansion within the ataxin-3 gene.
It is characterized by multi-system involvement and diverse clinical phenotypes, which cannot be fully explained the length of the CAG repeats.
One possible explanation for the phenotypic heterogeneity could be the presence of mitochondrial DNA mutations that modify disease severity. To pathogenesis (YU et al. 2009; NOBREGA et al. 2013) . However, the distinct pathogenic mechanisms of the CAG repeat expansion remain unclear, and toxicity of the widely expressed polyglutamine protein cannot fully explain the selective neuronal degeneration seen in this disease (MARUYAMA et al. 1995; PADIATH et al. 2005; YU et al. 2009; RAMOS et al. 2015) .
Mitochondrial DNA, which exists completely apart from the nuclear genome, contains 16,569 base pairs and codes for 37 genes. These genes are all necessary for the synthesis of mitochondrial proteins. Mitochondrial dysfunction can decrease ATP production, increase toxic free radicals and disrupt cytoplasmic calcium balance, leading to excitotoxicity and apoptosis (PETROZZI et al. 2007) . Mitochondrial dysfunction associated with several degenerative neurological diseases (WALDBAUM and PATEL 2010; PAREYSON et al. 2014) .
Nuclear DNA or mtDNA mutations can both cause mitochondrial dysfunction. Several groups have explored the relationship between spinocerebellar ataxia and mutations in mitochondrial DNA, such as
Casali (CASALI et al. 1999 ), Chinnery(CHINNERY et al. 2002 
Results

Polymorphisms analysis of the mtDNA
Among the 102 patients of SCA3/MJD, a total of 24 SNVs were detected in the genes of MT-LT1, and MT-ATP6, two of which were previously reported SNPs, and 22 of which were novel variants (Tab. 1-1). Only 10 SNVs were detected in the 100 healthy controls (Tab. 1-2). The T8772C variant was found in both patient and control groups. 
2010).In our study, we analyzed the mutations in several commonly reported mtDNA genes, including MT-LT1, MT-ND1, MT-CO2, MT-TK,
MT-ATP8 and MT-ATP6. Interestingly, we found 22 new SNVs in ATP8 and ATP6. Among these SNVs, the variant rates of A8701G and A8860G
were high (47.06% and 52.94%, respectively), and both cause replacement of the threonine with alanine. Threonine is neutral polar amino acid, and alanine is neutral non-polar amino acid. Thus, the threonine to alanine mutation may cause a structural change in the translated product, but whether it will cause a failure in energy metabolism is still unclear. Only when the mutation rate of the mtDNA reaches a certain threshold do the cells and organelles may show functional changes (CHEN et al. 2015) . In our study, the SNV rate in mtDNA is much higher in SCA3/MJD patients than the normal controls, which may indicate a role for mtDNA mutation in SCA3 pathogenesis. It is unclear whether these mutations are modifiers of disease, or whether they are a consequence of changes caused by repeat expansion in the ataxin-3 gene.
In previous studies, it was shown that mtDNA copy numbers from peripheral leucocytes in MELAS patients or MERRF patients correlated negatively with the mtDNA mutation rate (CHABI et al. 2003) . In an SCA3/MJD cell model, decreased antioxidant activity lead to increased mtDNA damage, including a decreased mtDNA copy number and the loss of 4977 base pairs2. In another cohort of SCA and Huntington's disease patients, Bing-Wen Soong showed that the decrease in mtDNA copy number from peripheral white blood cells negatively correlates with the number of CAG repeats, and proposed that mtDNA copy number could be a marker for these trinucleotide repeat diseases (LIU et al. 2008) . We analyzed the mtDNA copy numbers variant from peripheral white blood cells in both SCA3/MJD patients and healthy controls, and found a negative correlation between the relative mtDNA copy number and the number of CAG repeats in SCA3/MJD patients. There was no correlation with the age at testing, the age of onset, disease duration, ICARS scores or SARA scores, and we did not observe a significant difference in relative mtDNA copy number between SCA3/MJD patients and healthy controls.
In summary, our study demonstrated that the frequency of mutated mtDNA in SCA3/MJD patients was higher than in the healthy group, suggesting that poly-Q repeat length in this disease may be associated with mutations in mtDNA. The mtDNA relative copy number in SCA3/MJD patients was not significantly different compared with the healthy control group, indicating that mtDNA copy number is not a biomarker for disease severity in SCA3/MJD patients.
Subjects and methods
Patients and controls
One 
Analysis of the relative mtDNA copy number
The relative mtDNA copy number was measured using real-time PCR for the ND1 gene and normalized against the reference gene β -globin.
Pooled DNA from the Health Study participants served as the reference DNA pool, used to create a fresh standard curve on which the system was calibrated, which ranged from 0.16 to 20 ng/μL. All samples were assessed in triplicate, and the average of all three measurements was calculated. We used primers from Liu et al (LIU et al. 2003) for this study (Tab.4 
Statistical analysis
Statistical analysis was carried out with SPSS 22.0 and Excel 2010. All data were expressed as the means ± standard deviation. The Mann-Whitney U test was used for comparison of the relative mtDNA copy number between SCA3/MJD patients and healthy controls, and correlations of relative mtDNA copy number with CAG repeat, age at detection, age of onset, disease duration, ICARS scores and SARA scores were assessed by the Spearman correlation test. The data were considered significant when the P value was less than 0.05. 
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